Search - tctmd.com

Displaying 1 - 20 of 75

Sort: Relevancy | Date

News Daily News

High Adolescent BP Tied to Subclinical Disease in Middle Age

Michael O'Riordan

November 20, 2025

News Opinion CV Team Dispatch

September 2025 Dispatch for the CV Team

L.A. McKeown

September 30, 2025

News Daily News

FDA Approves Triple Therapy Polypill for High Blood Pressure

Michael O'Riordan

June 10, 2025

News Conference News AHA 2024

Indian Patients Do Well on Dual-Combination Pills for Hypertension: TOPSPIN

Caitlin E. Cox

November 22, 2024

News Daily News

Statins Effective For Primary Prevention in Old and Very Old

Michael O'Riordan

May 29, 2024

News Conference News ACC 2024

KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives

Shelley Wood

April 11, 2024

News Daily News

Top General Cardiology and CVD Prevention News of 2023

Yael L. Maxwell

January 03, 2024

News Daily News

Long-term ALLHAT Data Affirm Parity of Antihypertensive Meds

Todd Neale

December 06, 2023

News Conference News AHA 2023

Slash Dietary Sodium, Slash Blood Pressure: CARDIA-SSBP

Michael O'Riordan

November 12, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Opinion CV Team Dispatch

May 2023 News Roundup

L.A. McKeown

May 01, 2023

News Daily News

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Yael L. Maxwell

April 12, 2023

News Daily News

Hypertension Drug Effects Differ From Person to Person, PHYSIC Trial Shows

L.A. McKeown

April 12, 2023

News Daily News

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Michael O'Riordan

April 11, 2023

News Daily News

Longer and Greater Risk Factor Exposure, More CVD

Caitlin E. Cox

March 23, 2023

News Conference News ACC 2023

HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hypertension

Todd Neale

March 08, 2023

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Conference News AHA 2022

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

Michael O'Riordan

November 09, 2022

News Conference News AHA 2022

Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study

Michael O'Riordan

November 07, 2022

Advertisement

High Adolescent BP Tied to Subclinical Disease in Middle Age

September 2025 Dispatch for the CV Team

FDA Approves Triple Therapy Polypill for High Blood Pressure

Indian Patients Do Well on Dual-Combination Pills for Hypertension: TOPSPIN

Statins Effective For Primary Prevention in Old and Very Old

KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives

Top General Cardiology and CVD Prevention News of 2023

Long-term ALLHAT Data Affirm Parity of Antihypertensive Meds

Slash Dietary Sodium, Slash Blood Pressure: CARDIA-SSBP

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

May 2023 News Roundup

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Hypertension Drug Effects Differ From Person to Person, PHYSIC Trial Shows

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Longer and Greater Risk Factor Exposure, More CVD

HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hypertension

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content